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Avian Influenza 
A(H7N9) Virus  
Infection in  
Pregnant Woman, 
China, 2013
To the Editor: In February 2013, 
human infection with reassortant 
avian influenza A(H7N9) virus oc-
curred in eastern China. A total of 
135 laboratory-confirmed cases and 
44 deaths among case-patients have 
been reported as of August 11, 2013. 
Unlike infection with other H7 sub-
type viruses (e.g., H7N2, H7N3, and 
H7N7), which often cause mild-to-
moderate-human disease (1), infec-
tion with H7N9 subtype virus caused 
severe pneumonia and acute respira-
tory distress syndrome in most labo-
ratory-confirmed case-patients (2,3). 
Pregnant women are particularly sus-
ceptible to severe complications from 
influenza (seasonal and pandemic), 
and have an increased risk for mater-
nal death (4).
On March 30, 2013, a 25-year-
old pregnant woman came to the out-
patient department of a hospital in 
Zhenjiang, Jiangsu Province, China. 
She had cough and fever (temperature 
38.0°C), which had begun 2 days earli-
er. She also reported mild myalgia and 
mild sore throat. The patient had no 
any underlying medical conditions and 
was at 17 weeks gestation, as estimat-
ed by ultrasound. On April 5, she was 
admitted to the respiratory department 
of the hospital with a temperature of 
39.9°C, a leukocyte count of 7.9 ×109 
cells/L, and a lymphocyte count of 0.7 
× 109 cells/L.
On April 6, she was transferred to 
the intensive care unit because of short-
ness of breath, respiratory failure, and 
loss of consciousness. She was given 
mechanical ventilation, broad-spec-
trum antimicrobial drugs, oseltamivir, 
gamma-globulin, antifibrotic therapy 
(glutathione), and nutritional support. 
Oseltamivir (150 mg/d, 2 times/d) had 
been administered during April 6–12. 
A chest radiograph showed extensive 
infiltrates of both lungs.
On April 21, she regained con-
sciousness, and her condition stabi-
lized over the next few days. On April 
23, she was extubated, transferred to 
the common ward, and given nasal 
oxygen supplementation and antimi-
crobial and antifibrotic drug therapy. 
Her condition improved gradually, 
and on May 14 she was discharged in 
good health without fetal abnormality.
The fetus was monitored daily by 
using ultrasound to check the heart 
rate; fetal heart rate and activity were 
normal during hospitalization. The fe-
tus continued to grow appropriately 
and was delivered by cesarean sec-
tion at 35 weeks’ gestation on July 17 
(length 48 cm, weight 3,300 g, and 
Apgars scores of 9 at 1 min and 10 at 
5 min). The clinical timeline for the 
case-patient is shown in the Figure.
The patient and her husband lived 
in a house with her husband’s parents. 
No live poultry were present in the 
residential district, but the husband’s 
parents worked as pork butchers in a 
live animal market ≈500 m from the 
residential district. Several kinds of 
live poultry (e.g., chicken, duck, pi-
geon, and quail) were sold in the mar-
ket. During the 2 weeks before illness 
onset, the patient did not have contact 
with persons known to be febrile. 
However, during that time, she visited 
the live animal market once. Eighteen 
potential close contacts of the patient 
were identified (15 health care work-
ers and 3 household members). Respi-
ratory symptoms did not develop in 
any of these contacts during a 7-day 
surveillance period.
Four methods were used for labo-
ratory diagnosis: real-time reverse 
transcription PCR, virus isolation, 
full-genome sequencing, and modi-
fied hemagglutination inhibition as-
says. Clinical samples tested were 2 
throat swab specimens obtained from 
the patient on April 6 and 7, 38 paired 
serum samples obtained from the pa-
tient and close contacts during the 
acute and convalescent phases of in-
fection, and 6 environmental samples 
(2 avian feces samples and 4 poultry 
cage specimens obtained from the live 
animal market that the patient visited). 





were positive for the hemagglutinin 
(HA) and neuraminidase genes of 
avian influenza A (H7N9) virus. Of 6 
environmental samples, 5 were posi-
tive for (H7N9) virus HA genes. No 
(H7N9) virus HA antibodies were 
detected from paired serum samples 
from all 18 close contacts.
Two virus strains were isolated: 
1 from a patient specimen (A/Zhen-
jiang/1/2013) and 1 from a chicken 
cage specimen (A/environment/
Zhenjiang/4/2013) (GenBank ac-
cession nos. KF007057–KF007064 
and KF007009–KF007016, respec-
tively). Genome comparison showed 
that isolates had a nucleotide iden-
tity of 96.8%–99.8%, indicating an 
amino acid identity of 98·2%–99·6%. 
Phylogenetic analysis showed that 
5 genes (HA, nucleoprotein, neur-
aminidase, matrix, and nonstructural 
protein) of the 2 isolates belonged to 
the same clade. However, the 3 poly-
merase genes (polymerase basic 1, 
polymerase basic 2, and polymerase 
acidic) clustered in a different clade. 
These results suggested that the 2 
strains originated from an indepen-
dent reassortment mechanism and 
that the H7N9 subtype viruses had 
undergone genetic reassortment to 
generate multiple novel genotypes 
in China.
According to epidemiologic 
and clinical data for infections with 
avian influenza A(H7N9) virus, 
most patients with severe illness, 
including severe pneumonia and 
acute respiratory distress syndrome, 
were elderly men with underlying 
medical conditions (2,3). Our find-
ings suggest that pregnancy might 
be a risk factor for clinically severe 
influenza in young women infected 
with H7N9 subtype virus.
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Peste des Petits 
Ruminants Virus, 
Mauritania
To the Editor: Peste des petits ru-
minants virus (PPRV; genus Morbilli-
virus, family Paramyxoviridae) causes 
severe infectious disease in sheep and 
goats in Africa and Asia. Pneumo-en-
teritis clinical signs are dominated by 
ocular and nasal discharge, and mor-
tality rates are high (1). Four distinct 
lineages of PPRV have been described 
on the basis of a phylogenetic analysis 
of a cDNA fragment of the nucleopro-
tein (NP) gene (2): lineages I and II are 
found in western Africa (1,3,4), lineage 
III in eastern Africa and the Middle 
East, and lineage IV in Asia. Recent 
studies have shown changes in this dis-
tribution (1,5), including the emergence 
of PPRV lineage IV in northeastern and 
northern Africa (5). Sparse serologic 
results (6,7) are available regarding 
PPRV spread in Mauritania or genetic 
features of circulating PPRV strains.
A seroprevalence survey was im-
plemented in October 2010 to assess 
PPRV spatial distribution in Maurita-
nia. The study was limited to 8 south-
ern provinces (wilayas), which cov-
ered 99.3% of the national sheep and 
goat stocks (online Technical Appen-
dix Figure 1, wwwnc.cdc.gov/EID/
article/20/2/13-1345-Techapp1.pdf). 
Of 40 districts (mougataas), 21 were 
randomly selected. A single geograph-
ic point was randomly sampled within 
each of the selected mougataas, and 
100 small ruminants were sampled in 
a 7-km radius around the coordinates. 
None of the mougataas in which sam-
pling occurred had a PPRV vaccina-
tion program.
In addition, field veterinary of-
ficers from Trarza and Tagant Prov-
inces were asked to report suspected 
outbreaks of peste des petits ruminants 
disease (PPR) during January–March 
2012. All outbreaks were investigated, 
and biologic samples were collected 
for laboratory diagnostics. 
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